Literature DB >> 14729713

Transferrin-binding protein B of Neisseria meningitidis: sequence-based identification of the transferrin-Binding site confirmed by site-directed mutagenesis.

Geneviève Renauld-Mongénie1, Laurence Lins, Tino Krell, Laure Laffly, Michèle Mignon, Monique Dupuy, Rose-May Delrue, Françoise Guinet-Morlot, Robert Brasseur, Ling Lissolo.   

Abstract

A sequence-based prediction method was employed to identify three ligand-binding domains in transferrin-binding protein B (TbpB) of Neisseria meningitidis strain B16B6. Site-directed mutagenesis of residues located in these domains has led to the identification of two domains, amino acids 53 to 57 and 240 to 245, which are involved in binding to human transferrin (htf). These two domains are conserved in an alignment of different TbpB sequences from N. meningitidis and Neisseria gonorrhoeae, indicating a general functional role of the domains. Western blot analysis and BIAcore and isothermal titration calorimetry experiments demonstrated that site-directed mutations in both binding domains led to a decrease or abolition of htf binding. Analysis of mutated proteins by circular dichroism did not provide any evidence for structural alterations due to the amino acid replacements. The TbpB mutant R243N was devoid of any htf-binding activity, and antibodies elicited by the mutant showed strong bactericidal activity against the homologous strain, as well as against several heterologous tbpB isotype I strains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729713      PMCID: PMC321495          DOI: 10.1128/JB.186.3.850-857.2004

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  32 in total

Review 1.  NPS@: network protein sequence analysis.

Authors:  C Combet; C Blanchet; C Geourjon; G Deléage
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  Differential functionalities of amphiphilic peptide segments of the cell-septation penicillin-binding protein 3 of Escherichia coli.

Authors:  M Marrec-Fairley; A Piette; X Gallet; R Brasseur; H Hara; C Fraipont; J M Ghuysen; M Nguyen-Distèche
Journal:  Mol Microbiol       Date:  2000-09       Impact factor: 3.501

3.  Characterisation of the meningococcal transferrin binding protein complex by photon correlation spectroscopy.

Authors:  I C Boulton; A R Gorringe; R J Carr; B Gorinsky; C L Joannou; R W Evans
Journal:  FEBS Lett       Date:  1997-09-08       Impact factor: 4.124

4.  Biochemical evidence for a conserved interaction between bacterial transferrin binding protein A and transferrin binding protein B.

Authors:  C A Fuller; R Yu; S W Irwin; A B Schryvers
Journal:  Microb Pathog       Date:  1998-02       Impact factor: 3.738

5.  Identification of sequences in human transferrin that bind to the bacterial receptor protein, transferrin-binding protein B.

Authors:  M D Retzer; R H Yu; A B Schryvers
Journal:  Mol Microbiol       Date:  1999-04       Impact factor: 3.501

Review 6.  Iron acquisition systems in the pathogenic Neisseria.

Authors:  A B Schryvers; I Stojiljkovic
Journal:  Mol Microbiol       Date:  1999-06       Impact factor: 3.501

7.  Characterization of genetic exchanges between various highly divergent tbpBs, having occurred in Neisseria meningitidis.

Authors:  M Legrain; B Rokbi; D Villeval; E Jacobs
Journal:  Gene       Date:  1998-02-16       Impact factor: 3.688

8.  Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine.

Authors:  B Rokbi; G Renauld-Mongenie; M Mignon; B Danve; D Poncet; C Chabanel; D A Caugant; M J Quentin-Millet
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

9.  Both the full-length and the N-terminal domain of the meningococcal transferrin-binding protein B discriminate between human iron-loaded and apo-transferrin.

Authors:  G Renauld-Mongénie; M Latour; D Poncet; S Naville; M J Quentin-Millet
Journal:  FEMS Microbiol Lett       Date:  1998-12-01       Impact factor: 2.742

10.  Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines.

Authors:  L Lissolo; G Maitre-Wilmotte; P Dumas; M Mignon; B Danve; M J Quentin-Millet
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more
  6 in total

1.  Towards the identification of type II secretion signals in a nonacylated variant of pullulanase from Klebsiella oxytoca.

Authors:  Olivera Francetić; Anthony P Pugsley
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

2.  Identification of transferrin-binding domains in TbpB expressed by Neisseria gonorrhoeae.

Authors:  Amanda J DeRocco; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

Review 3.  The transferrin-iron import system from pathogenic Neisseria species.

Authors:  Nicholas Noinaj; Susan K Buchanan; Cynthia Nau Cornelissen
Journal:  Mol Microbiol       Date:  2012-09-07       Impact factor: 3.501

4.  Genome-Wide Subtraction Analysis and Reverse Vaccinology to Detect Novel Drug Targets and Potential Vaccine Candidates Against Ehrlichia chaffeensis.

Authors:  Samira Sabzi; Shahla Shahbazi; Narjes Noori Goodarzi; Fatemeh Haririzadeh Jouriani; Mehri Habibi; Negin Bolourchi; Amir Mirzaie; Farzad Badmasti
Journal:  Appl Biochem Biotechnol       Date:  2022-09-02       Impact factor: 3.094

5.  Distribution of transferrin binding protein B gene (tbpB) variants among Neisseria species.

Authors:  Odile B Harrison; Martin C J Maiden; Bachra Rokbi
Journal:  BMC Microbiol       Date:  2008-04-22       Impact factor: 3.605

6.  Conformational instability of human prion protein upon residue modification: a molecular dynamics simulation study.

Authors:  Kourosh Bamdad; Hossein Naderi-Manesh; Artur Baumgaertner
Journal:  EXCLI J       Date:  2014-03-03       Impact factor: 4.068

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.